Delivery Order SPE2DB20D3103-SPE2DB25FQ1D5
- Not listed
- The Defense Logistics Agency awarded a $82,059.20 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Menopur 75 Unit Vials. This competitively awarded, non-set-aside contract utilizes firm fixed price pricing and is scheduled for completion by July 29, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $103,790.69 to AmerisourceBergen Drug Corp for the supply of Menopur 75 Unit Vials. This competitively awarded, firm fixed-price contract was executed on July 29, 2025, with an ultimate completion date of July 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $58,448.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Menopur 75 Unit Vials. The contract was awarded on August 27, 2025, with an ultimate completion date of August 28, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $36,530.50 delivery order to AmerisourceBergen Drug Corp for Menopur 75 Unit vials, with a completion date of September 2, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order valued at $19,980.83 to AmerisourceBergen Drug Corp for the supply of Menopur 75 Unit Vials. The contract is firm fixed price with no set-aside designation and carries an ultimate completion date of August 18, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a competitive award under the company's existing contract vehicle with DLA....
- The Defense Logistics Agency awarded a $8,036.71 delivery order to AmerisourceBergen Drug Corp for Menopur 75 Unit Vials, with an ultimate completion date of July 24, 2025. This contract employs firm fixed pricing and was competitively awarded with no set-aside designation. The place of performance is the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $24,529.17 delivery order to AmerisourceBergen Drug Corp for 75-unit vials of Menopur, a fertility medication used in assisted reproductive procedures. This is a firm fixed price, competitively awarded contract with an ultimate completion date of July 24, 2025, with performance to be completed in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition among qualified pharmaceutical vendors. This delivery order...
- The Defense Logistics Agency awarded a $46,140.29 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 75-unit vials of Menopur, a fertility medication commonly used in assisted reproductive therapy. This non-competitive delivery order was issued on September 2, 2025, with an ultimate completion date of September 3, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical supply transaction under the...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Menopur 75 Unit Vials, a fertility medication used in assisted reproductive procedures. This firm fixed price delivery order, valued at $184,393.57, is set to be completed by August 29, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award was made competitively without a set-aside designation,...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $43,836.60 for 75-unit vials of Menopur, a fertility medication, from the Defense Logistics Agency's Medical Supply Chain on August 27, 2025. The contract utilizes a firm fixed-price delivery order structure with an ultimate completion date of August 28, 2025. This award was made through competitive procedures without any set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility, where...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ1D5Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $72,376.16 to AmerisourceBergen Drug Corp for the supply of Menopur 75 Unit vials. The contract, issued on September 2, 2025, with an ultimate completion date of September 3, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award based on open competition. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, supplies a broad range of medications and medical supplies to support military healthcare programs worldwide. The Menopur product—a hormone treatment pharmaceutical—falls within the company's extensive portfolio of specialty medications and therapeutic products delivered to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems through this flexible contract framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $72.4k | 9/2/25 |